LivaNova PLC (LIVN)
Makes implantable devices that regulate nerve activity to treat epilepsy, depression, and sleep apnea.
$81.82+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+98.9%
The outlook
LIVN is trading near the top of its 52-week range with analyst sentiment firmly on the buy side. The stock sits above both its 50- and 200-day moving averages, and the average analyst target sits about 4% above the current price. The trailing P/E of 41.7 reflects a premium valuation relative to recent earnings.
What’s behind the score
Analyst consensusBuy — 1.7 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Price targetAvg target +4% vs current price
Analyst price target
~12-month · 10 analysts$84.80average target+3.6% vs now
Now $81.82
Low $67.00High $95.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$4.49B
52-wk high
$85.27
52-wk low
$41.02
50-day avg
$78.03
200-day avg
$65.88
Trailing P/E
41.7